Funding Details
- Awarder
- Inbox
- Date Award
- December 11, 2018
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$13,000,000
Company Info
- Founders
- Susan Dillon, PhD
- Company Description
- Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
- Market
- Oncology and Immunology
- Location
-
Philadelphia,
PA,
USA
- Coinvestors
- BioMotiv, BVF Partners, Cowen Healthcare Investments, HealthCap, Ionis Pharmaceuticals, Johnson & Johnson Innovation, Northpond Ventures, Ridgeback Capital Management
Links